On a GAAP basis, diluted third-quarter EPS totaled $1.68.
Monsanto reaffirmed its full-year adjusted EPS guidance of $4.50 to $4.55 and earnings growth in 2014 in the mid-teens. The consensus estimate for 2013 EPS is $4.60, and the estimate for 2014 is $5.30. Monsanto’s guidance is weaker for this year, and pretty much in line with the consensus estimate for next year.
Monsanto’s CEO said:
[W]e’re on track to deliver more than 20 percent ongoing earnings growth in fiscal year 2013 and in a very strong position to build on that success with continued growth next year. Our optimism reflects the expanding opportunity we see to unlock successive layers of growth next year and beyond as our focus on farmers, new product platforms and operating efficiency combine to build continued momentum.
The company has posted EPS of $5.01 for the first nine months of its fiscal year, and analysts are expecting a net loss of $0.35 per share for the fourth quarter ending in August. The math works out to full-year EPS of $4.66, higher than either Monsanto’s own estimate or the consensus estimate of $4.60. Shares could get beaten up today.
Monsanto’s shares are up fractionally in pre-market trading this morning, at $101.40 in a 52-week range of $76.89 to $109.33. Thomson Reuters had a consensus analyst price target of around $117.10 before today’s report.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.